---
title: "Ocular Therapeutix grants inducement awards to new hires, including options priced at $8.4 per share"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295272750.md"
description: "Ocular Therapeutix granted inducement equity awards to eight new non-executive employees under its 2019 Inducement Stock Incentive Plan. Effective August 3, 2026, the grants include stock options for 53,975 shares at an exercise price of $8.4 per share with a 10-year term and four-year vesting period, as well as restricted stock units for 17,450 shares vesting over three years."
datetime: "2026-08-07T20:05:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295272750.md)
  - [en](https://longbridge.com/en/news/295272750.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295272750.md)
---

# Ocular Therapeutix grants inducement awards to new hires, including options priced at $8.4 per share

-   Ocular Therapeutix granted inducement equity awards to eight newly hired non-executive employees under its 2019 Inducement Stock Incentive Plan. \* Grants effective Aug. 3, 2026 cover stock options for 53,975 shares, exercise price $8.4, 10-year term, vesting over four years. \* Restricted stock units cover 17,450 shares, vesting over three years in equal annual installments. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ocular Therapeutix Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608071605PRIMZONEFULLFEED9806171) on August 07, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [OCUL.US](https://longbridge.com/en/quote/OCUL.US.md)

## Related News & Research

- [Ocular Therapeutix Earns Buy Rating as Axpaxli Differentiation and LUGANO TKI Data Bolster Confidence in Lead Asset](https://longbridge.com/en/news/296129081.md)
- [Why Is Ocular Therapeutix Stock Gaining Monday?](https://longbridge.com/en/news/296134890.md)
- [In the AI Era, Duolingo Is Betting on Humans](https://longbridge.com/en/news/296129188.md)
- [Elkem terminates share option program, cancels 5,017,333 outstanding options](https://longbridge.com/en/news/295490899.md)
- [Daré Bioscience prices USD 6 million registered direct offering at USD 1.37 per share](https://longbridge.com/en/news/296107389.md)